Ultrashort Cationic Lipopeptides and Lipopeptoids Selectively Induce Cytokine Production in Macrophages

被引:16
作者
Findlay, Brandon [1 ]
Mookherjee, Neeloffer [2 ]
Schweizer, Frank [1 ,3 ]
机构
[1] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada
[2] Univ Manitoba, Dept Internal Med & Immunol, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada
[3] Univ Manitoba, Dept Med Microbiol, Hlth Sci Ctr, Winnipeg, MB, Canada
来源
PLOS ONE | 2013年 / 8卷 / 02期
基金
加拿大自然科学与工程研究理事会;
关键词
DEFENSE PEPTIDE LL-37; ANTIMICROBIAL PEPTIDES; BACTERIAL-INFECTIONS; IMMUNE-RESPONSES; HUMAN CAP18; IN-VITRO; RECEPTOR; RESISTANCE; DISCOVERY; DISEASE;
D O I
10.1371/journal.pone.0054280
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A series of ultrashort lipopeptides and lipopeptoids were tested for their ability to induce cytokine production in macrophages. Fourteen compounds were found to strongly induce production of chemokines Gro alpha and IL-8, with a structural bias that was absent from previous antibacterial activity investigations. Compounds based on LysGlyLys and NLysGlyNLys sequences did not induce cytokine production, whereas those based on LysLysLys and NLysNLysNLys were active only when linked to a lipid tail at least sixteen carbons long. Three lipopeptides induced high levels of IL-8 production, above that of equivalent concentrations of cathelicidin LL-37, while no compound induced production of the pro-inflammatory cytokine TNF-alpha at or below 100 mu M. Two compounds, peptoids C16OH-NLysNLysNLys and C16OH-NHarNHarNHar, were selective for IL-8 production and did not induce TNF-alpha or IL-1 beta. These compounds may prove beneficial for in vivo treatment of infectious disease, with improved bioavailability over LL-37 due to their protease-resistant scaffold.
引用
收藏
页数:7
相关论文
共 40 条
[1]   Structure-Activity Relationships in Toll-Like Receptor 2-Agonists Leading to Simplified Monoacyl Lipopeptides [J].
Agnihotri, Geetanjali ;
Crall, Breanna M. ;
Lewis, Tyler C. ;
Day, Timothy P. ;
Balakrishna, Rajalakshmi ;
Warshakoon, Hemamali J. ;
Malladi, Subbalakshmi S. ;
David, Sunil A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (23) :8148-8160
[2]   Synthesis and anti-HIV activity of guanidinoglycosides [J].
Baker, TJ ;
Luedtke, NW ;
Tor, Y ;
Goodman, M .
JOURNAL OF ORGANIC CHEMISTRY, 2000, 65 (26) :9054-9058
[3]   Impact of LL-37 on anti-infective immunity [J].
Bowdish, DME ;
Davidson, DJ ;
Lau, YE ;
Lee, K ;
Scott, MG ;
Hancock, REW .
JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 77 (04) :451-459
[4]   TNF-mediated inflammatory disease [J].
Bradley, J. R. .
JOURNAL OF PATHOLOGY, 2008, 214 (02) :149-160
[5]   Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? [J].
Brogden, KA .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) :238-250
[6]   Multiple immune-modulatory functions of catheticidin host defense peptides [J].
Choi, Ka-Yee ;
Mookherjee, Neeloffer .
FRONTIERS IN IMMUNOLOGY, 2012, 3
[7]   Api88 Is a Novel Antibacterial Designer Peptide To Treat Systemic Infections with Multidrug-Resistant Gram-Negative Pathogens [J].
Czihal, Patricia ;
Knappe, Daniel ;
Fritsche, Stefanie ;
Zahn, Michael ;
Berthold, Nicole ;
Piantavigna, Stefania ;
Mueller, Uwe ;
Van Dorpe, Sylvia ;
Herth, Nicole ;
Binas, Annegret ;
Koehler, Gabriele ;
De Spiegeleer, Bart ;
Martin, Lisandra L. ;
Nolte, Oliver ;
Straeter, Norbert ;
Alber, Gottfried ;
Hoffmann, Ralf .
ACS CHEMICAL BIOLOGY, 2012, 7 (07) :1281-1291
[8]   Guanidylation and Tail Effects in Cationic Antimicrobial Lipopeptoids [J].
Findlay, Brandon ;
Szelemej, Paul ;
Zhanel, George G. ;
Schweizer, Frank .
PLOS ONE, 2012, 7 (07)
[9]   Investigating the antimicrobial peptide 'window of activity' using cationic lipopeptides with hydrocarbon and fluorinated tails [J].
Findlay, Brandon ;
Zhanel, George G. ;
Schweizer, Frank .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 40 (01) :36-42
[10]   Cationic Amphiphiles, a New Generation of Antimicrobials Inspired by the Natural Antimicrobial Peptide Scaffold [J].
Findlay, Brandon ;
Zhanel, George G. ;
Schweizer, Frank .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) :4049-4058